Integrated analysis identifies key genes underlying the bidirectional association between depression and renal...

Area of Science:

• Biomedical research
• Genetics
• Psychiatry

Background:

• Depression frequently co-occurs with end-stage renal disease (ESRD), but the underlying biological mechanisms are not well understood.
• Existing treatments for depression in ESRD patients offer symptomatic relief, yet the molecular interplay remains unclear.

Purpose of the Study:

• To investigate the biological mechanisms and molecular pathways linking end-stage renal disease (ESRD) and depression.
• To identify potential therapeutic targets for this common comorbidity.

Main Methods:

• Integrated analysis combining UK Biobank (UKB) cohort data with bioinformatics approaches.
• Gene expression analysis using Weighted Gene Co-expression Network Analysis (WGCNA) and Gene Expression Omnibus (GEO) database.
• Protein-protein interaction (PPI) network construction (STRING) and immune cell infiltration analysis (CIBERSORT).

Main Results:

• Confirmed a significant association between renal failure and depression in the UKB cohort.
• Identified enriched pathways related to acute inflammatory response and immune receptor activity.
• Discovered 23 hub genes, including CYP4F2, KCNA3, KISS1R, LILRA5, and ZC3H12D, implicated in the shared pathophysiology.

Conclusions:

• Reveals novel molecular and immune interactions underlying the comorbidity of renal failure and depression.
• Highlights LILRA5, CYP4F2, and KISS1R as potentially crucial players in the shared mechanisms.
• Identifies potential therapeutic targets and pathways for innovative treatment strategies.